Physician profile
Gregory L Primus
NPI 1295937555
$21,026.68
in general payments reported to CMS, 2019-2025
40 companies · $2,054 in 2025
The $2,054 reported for 2025 was more than what a typical Sports Medicine (Orthopaedic Surgery) provider received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,151 · 2020: $2,262 · 2021: $2,907 · 2022: $3,442 · 2023: $5,376 · 2024: $2,835 · 2025: $2,054.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $4,511 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $3,750 · Food and Beverage: $2,004.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $4,511.35 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $3,750.00 |
| Food and Beverage | $2,003.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $15,489.77 | 2019-2025 | |
| Medwest Associates | $1,498.42 | 2019-2023 | |
| Lightbody Medical Technologies INC | $1,461.97 | 2024-2025 | |
| Zimmer Biomet Holdings, INC. | $367.30 | 2019-2020 | |
| Edwards Lifesciences Corporation | $280.88 | 2022 | |
| Depuy Synthes Sales INC. | $196.93 | 2019-2024 | Monovisc, Velys |
| Smith+Nephew, INC. | $186.84 | 2019-2022 | |
| Stryker Corporation | $173.08 | 2021-2024 | Augment Injectable, Ortholoc 2 Lapifuse, Viaflow |
| Pacira Therapeutics, INC. | $146.49 | 2019-2021 | |
| Electronic Waveform Lab, INC. | $145.59 | 2020-2021 | |
| Orthofix Medical, INC. | $139.79 | 2019-2025 | Physio-Stim |
| Bioventus LLC | $125.62 | 2019-2024 | Durolane |
| Ferring Pharmaceuticals INC. | $100.73 | 2019-2025 | Euflexxa |
| Pacira Pharmaceuticals Incorporated | $93.32 | 2020-2024 | Zilretta, Exparel |
| Ermi LLC | $79.01 | 2019-2025 |
Show all 40 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $48.87 | 2019-2023 | |
| Ortho Solutions INC | $37.47 | 2021 | |
| Linvatec Corporation | $36.96 | 2023-2024 | Biobrace 23mm, Allograft Tissue |
| Heraeus Medical, LLC. | $31.26 | 2022-2025 | |
| Astrazeneca Pharmaceuticals LP | $26.91 | 2024 | Wainua |
| Avanos Medical | $26.51 | 2023 | Trivisc Sodium Hyaluronate |
| Wright Medical Technology, INC. | $26.26 | 2019 | |
| Vertex Pharmaceuticals Incorporated | $26.00 | 2025 | |
| Si-Bone, INC. | $23.52 | 2019 | |
| Kerecis Limited | $22.50 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide, Kerecis Omega3 Surgiclose |
| Axogen | $20.94 | 2019 | |
| Endo Pharmaceuticals INC. | $19.41 | 2023 | Xiaflex |
| Moximed, INC | $18.92 | 2025 | Misha Knee System, Small, Left |
| Polynovo North America LLC | $17.63 | 2025 | Novosorb Btm |
| Heron Therapeutics, INC. | $17.51 | 2022 | |
| Checkpoint Surgical, INC | $17.44 | 2021 | |
| Kinex Medical Company LLC | $16.86 | 2019 | |
| Davol INC. | $16.25 | 2023 | Arista Ah Flexitip |
| Kci USA, INC. | $15.71 | 2021 | |
| Intellijoint Surgical INC. | $15.37 | 2021 | |
| Osteocentric Technologies, INC. | $13.52 | 2023 | Osteocentric 4.0 X 130mm Locking Bone Screw Fastener St |
| Integra Lifesciences Corporation | $12.81 | 2020 | |
| Conformis, INC. | $11.67 | 2022 | |
| Hydrocision, INC. | $11.24 | 2020 | |
| Ethicon US, LLC | $9.40 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gregory Primus listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.